Royce & Associates LP reduced its position in EverQuote, Inc. (NASDAQ:EVER - Free Report) by 23.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 449,722 shares of the company's stock after selling 140,430 shares during the quarter. Royce & Associates LP owned 1.27% of EverQuote worth $8,990,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of EVER. Charles Schwab Investment Management Inc. lifted its position in EverQuote by 255.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 240,482 shares of the company's stock worth $5,072,000 after buying an additional 172,785 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of EverQuote by 636.0% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 104,729 shares of the company's stock worth $2,209,000 after acquiring an additional 90,500 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of EverQuote by 10.4% in the 3rd quarter. Geode Capital Management LLC now owns 595,155 shares of the company's stock valued at $12,554,000 after purchasing an additional 56,114 shares in the last quarter. Barclays PLC boosted its stake in shares of EverQuote by 331.2% in the 3rd quarter. Barclays PLC now owns 50,983 shares of the company's stock valued at $1,076,000 after purchasing an additional 39,160 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of EverQuote by 3,022.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 385,629 shares of the company's stock valued at $8,133,000 after purchasing an additional 373,280 shares during the last quarter. 91.54% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
EVER has been the subject of several recent research reports. JPMorgan Chase & Co. boosted their price target on shares of EverQuote from $25.00 to $29.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 25th. Raymond James raised EverQuote from an "outperform" rating to a "strong-buy" rating and set a $35.00 target price for the company in a research note on Thursday, December 26th. Needham & Company LLC raised their price target on EverQuote from $30.00 to $38.00 and gave the stock a "buy" rating in a research report on Tuesday, February 25th. Finally, Canaccord Genuity Group decreased their price target on EverQuote from $35.00 to $30.00 and set a "buy" rating on the stock in a research note on Monday, February 24th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $32.33.
Read Our Latest Analysis on EVER
EverQuote Stock Performance
Shares of NASDAQ EVER traded up $0.66 during trading hours on Friday, hitting $28.71. The company's stock had a trading volume of 1,098,265 shares, compared to its average volume of 515,142. The business has a 50-day simple moving average of $22.60 and a 200-day simple moving average of $20.60. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of 84.44 and a beta of 1.01. EverQuote, Inc. has a 12 month low of $16.63 and a 12 month high of $29.07.
EverQuote (NASDAQ:EVER - Get Free Report) last announced its quarterly earnings results on Monday, February 24th. The company reported $0.33 EPS for the quarter, topping analysts' consensus estimates of $0.15 by $0.18. EverQuote had a return on equity of 13.94% and a net margin of 3.31%. The company had revenue of $147.46 million during the quarter, compared to analyst estimates of $133.83 million. On average, equities research analysts forecast that EverQuote, Inc. will post 0.72 EPS for the current year.
Insider Buying and Selling
In other news, CAO Jon Ayotte sold 7,647 shares of the company's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $25.72, for a total value of $196,680.84. Following the sale, the chief accounting officer now directly owns 58,045 shares of the company's stock, valued at $1,492,917.40. This represents a 11.64 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jayme Mendal sold 65,117 shares of the stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $28.07, for a total transaction of $1,827,834.19. Following the completion of the transaction, the chief executive officer now owns 619,156 shares of the company's stock, valued at approximately $17,379,708.92. The trade was a 9.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 122,428 shares of company stock valued at $3,045,162 over the last three months. Corporate insiders own 29.79% of the company's stock.
EverQuote Company Profile
(
Free Report)
EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.
Further Reading

Before you consider EverQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.
While EverQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.